The document discusses EU funding opportunities for health research and innovation under Horizon 2020. Horizon 2020 is the EU's 2014-2020 program for research and innovation, with €80 billion allocated. It focuses on three priorities: excellent science, industrial leadership, and societal challenges. In the area of health, challenges include aging populations, disease burden, and pressure on healthcare systems. The goals are to translate science into benefits, improve outcomes, support healthcare sectors, and promote healthy aging. The document provides details on past funding amounts under FP7 and lists several international consortia supported. It outlines the structure and goals of the International Rare Diseases Research Consortium to develop 200 new therapies and means to diagnose rare diseases by 2020.
1. Attracting EC
Funding
The Human Variome Project
5th Biennial Meeting
19th-23rd May, 2014
Paris
Diana Salmen
Innovative and Personalised Medicine Unit
Health Research Directorate
DG Research & Innovation
2. Research and
Innovation
HORIZON 2020
• The EU’s 2014-20 programme
for research & innovation
(around € 80 billion)
• A core part of Europe 2020, Innovation
Union & European Research Area
• Three priorities: Excellent science,
Industrial leadership, Societal challenges
4. Research and
Innovation
FP7 'Health' – the largest
multi-national fund…
• …for collaborative
research
• …to fund excellence
• …to bring together
scientists
• …to tackle global
challenges
5. Research and
Innovation
Key figures
6 b€ invested to date
1,000 projects
11,000 teams
3,500 organisations
130 countries
First outcomes
(on 329 closed projects = 1/3 of funded projects)
200 patent applications
9,000 publications
3,3 average SJR* publication
30 spin-offs created
* SCImago Journal Ranking
9. Research and
Innovation
Basic principles
• Teams up public and private organisations investing in
rare diseases research
• Research funders with relevant programmes >$10
million US over a 5-year period can join & work
together
• Each organisation funds research its own way
• Funded projects adhere to a common framework
• Agree to share data / standards
Alignment – Flexibility - Commitment
10. Research and
Innovation
Executive Committee
Chair: Paul Lasko
Diagnostics
Chair: Kym Boycott
Interdisciplinary
Chair: Hanns Lochmueller
Therapies
Chair: Yann Le Cam
Scientific Committees
Working Groups
EU-funded SUPPORT-IRDiRC provides organisational
support for Executive and Scientific Committees and Working Groups
Coordinator: Prof. Ségolène Aymé, INSERM
IRDiRC Governance Structure
14. Research and
Innovation
The International Human Epigenome Consortium (IHEC) is a global consortium
with the primary goal of providing free access to high-resolution reference
human epigenome maps for normal and disease cell types to the research
community.
EU
Germany
USA
JapanKorea
Canada
http://ihec-epigenomes.org/
15. Research and
Innovation
At a Glance
Generate reference maps of human epigenomes for key cellular states
relevant to health and disease.
Ambitious goal to complete 1000 epigenomes
Rapid Data Release, Data Coordination, Archiving
Environment Disease Aging
Translation into Improved Human Health
Mechanism Prevention Diagnosis Therapy
18. Research and
Innovation
• Challenge driven
• Broad topics
• Less prescriptive topics
• Two-year work programme
• Stronger focus on the end users
19. Research and
Innovation
• Simplified eligibility criteria
• Simpler rules for grants
• Transparent funding rates
• New SME instrument
• Successful project running quicker
20. Research and
Innovation
• Horizon 2020 is open
• Automatic funding
• Member States
• Associated countries
• Countries in Annex of the WP
• Exceptions
22. Research and
Innovation
• Ageing population
• Increased disease burden
• Unsustainable and unequal
healthcare systems
• Healthcare sector under
pressure to reform
23. Research and
Innovation
• Translating science to benefit citizens
• Improve health outcomes
• Support a competitive healthcare sector
• Test and demonstrate new healthcare
models, approaches and tools
• Promote healthy and active ageing
24. The Work Programme 2014 - 2015
Call for 'co-ordination activities'
16 topics (11 in 2014, 5 in 2015)
Call 'personalising health and care'
34 topics (15 in 2014, 17 in 2015, 2 open in both years)
+ 8 other actions
not subject to calls for proposals
26. Research &
Innovation
Understanding
health, ageing &
disease
Improving health
information, data
exploitation and
providing an evidence
base for health policies
and regulation
Integrated,
sustainable,
citizen-centered
care
Innovative
treatments and
technologies
Improving
diagnosis
Implementing personalized medicine in healthcare settings
Effective health
promotion, disease
prevention,
preparedness and
screening
Advancing active
and healthy aging